| For: | Wang CD, Zhang BX, Song J. Lipid metabolic reprogramming in colorectal cancer: Insights to mechanisms and therapeutics. World J Gastrointest Oncol 2025; 17(10): 109398 [PMID: 41114120 DOI: 10.4251/wjgo.v17.i10.109398] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v17/i10/109398.htm |
| 编号 | Citing Articles |
| 1 |
Hanrui Liu, Tao Zhou, Laiyuan Wang, Fangchao Liu, Dongfeng Gu. The role of PCSK9 in cancer risk: Population-level evidence and mechanistic insights. Oncology and Translational Medicine 2026; doi: 10.1097/ot9.0000000000000141
|
| 2 |
ShuangShuang Zhang, Kunshan Li, Dong-Dong Yu, Ya-Ying Lin, Lu Zhu, Pei-Han Wang, Guo-Na Li, Yan Huang, Hong-Xiao Xu, Ming Zhang. Exploring the Relationship Between Colitis-Associated Cancer and Lipid Metabolism Reprogramming from the Perspective of Inflammation-Cancer Transformation. Journal of Inflammation Research 2026; doi: 10.2147/JIR.S583726
|